DA Davidson Downgrades First Bancorp to Neutral, Lowers Price Target to $42
DA Davidson analyst Kevin Fitzsimmons downgrades First Bancorp (NASDAQ:FBNC) from Buy to Neutral and lowers the price target from $43 to $42.
DA Davidson Downgrades Southern First Bancshares to Neutral, Lowers Price Target to $50
DA Davidson analyst Kevin Fitzsimmons downgrades Southern First Bancshares (NASDAQ:SFST) from Buy to Neutral and lowers the price target from $52 to $50.
Barclays Downgrades Charter Communications to Underweight, Lowers Price Target to $388
Barclays analyst Kannan Venkateshwar downgrades Charter Communications (NASDAQ:CHTR) from Equal-Weight to Underweight and lowers the price target from $436 to $388.
Pivotal Research Downgrades Sirius XM Holdings to Hold, Lowers Price Target to $7.1
Pivotal Research analyst Jeffrey Wlodarczak downgrades Sirius XM Holdings (NASDAQ:SIRI) from Buy to Hold and lowers the price target from $7.55 to $7.1.
Bernstein Downgrades Vodafone Group to Market Perform
Bernstein analyst Stan Noel downgrades Vodafone Group (NASDAQ:VOD) from Outperform to Market Perform.
Wolfe Research Downgrades Plains All American to Peer Perform
Wolfe Research analyst Keith Stanley downgrades Plains All American (NASDAQ:PAA) from Outperform to Peer Perform.
Wells Fargo Downgrades Stanley Black & Decker to Equal-Weight, Announces $105 Price Target
Wells Fargo analyst Joseph O'Dea downgrades Stanley Black & Decker (NYSE:SWK) from Overweight to Equal-Weight and announces $105 price target.
Evercore ISI Group Downgrades Ultragenyx Pharmaceutical to In-Line, Lowers Price Target to $60
Evercore ISI Group analyst Liisa Bayko downgrades Ultragenyx Pharmaceutical (NASDAQ:RARE) from Outperform to In-Line and lowers the price target from $95 to $60.
Vertical Research Downgrades Stanley Black & Decker to Hold
Vertical Research analyst Jeffrey Sprague downgrades Stanley Black & Decker (NYSE:SWK) from Buy to Hold.
Susquehanna Downgrades Roku to Neutral, Lowers Price Target to $70
Susquehanna analyst Shyam Patil downgrades Roku (NASDAQ:ROKU) from Positive to Neutral and lowers the price target from $200 to $70.